Biospecifics Tech Cp (BSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,957 | 3,744 | -4,544 | -3,363 | -1,629 |
| Depreciation Amortization | 36 | 56 | 32 | 250 | 196 |
| Accounts receivable | 5,617 | -6,844 | -58 | -27 | -11 |
| Other Working Capital | 4,156 | -8,372 | 737 | -1,299 | 2,320 |
| Other Operating Activity | -4,127 | 8,315 | 387 | 2,362 | -312 |
| Operating Cash Flow | $3,725 | $-3,101 | $-3,447 | $-2,078 | $565 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -3,649 | 75 | -975 | N/A | N/A |
| PPE Investments | N/A | 8 | N/A | 12 | -18 |
| Purchase Sale Intangibles | N/A | -1,250 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -1,250 | 0 | 6,047 | 433 |
| Investing Cash Flow | $-3,649 | $-1,167 | $-975 | $6,059 | $415 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 2 |
| Debt Issued | N/A | N/A | N/A | N/A | -1,575 |
| Common Stock Issued | 380 | 6,262 | 123 | N/A | 14 |
| Other Financing Activity | 0 | 1,431 | 0 | -153 | -227 |
| Financing Cash Flow | $380 | $7,694 | $123 | $-153 | $-1,786 |
| Beginning Cash Position | 3,494 | 69 | 4,367 | 539 | 1,346 |
| End Cash Position | 3,950 | 3,494 | 69 | 4,367 | 539 |
| Net Cash Flow | $456 | $3,426 | $-4,299 | $3,828 | $-806 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,725 | -3,101 | -3,447 | -2,078 | 565 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -18 |
| Free Cash Flow | 3,725 | -3,101 | -3,447 | -2,078 | 547 |